The Polypeptide N-acetylgalactosaminyltransferase 4 Exhibits Stage-dependent Expression in Colorectal Cancer and Affects Tumorigenesis, Invasion and Differentiation
Overview
Authors
Affiliations
The aberrant expression of mucin-type O-glycosylation plays important roles in cancer malignancy. The polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-Ts) are a family of conserved enzymes that initiate the mucin-type O-glycosylation in cells. In human, consistent up- or down-regulation of ppGalNAc-Ts expression during cancer development has been frequently reported. Here, we provide evidence that ppGalNAc-T4 shows a stage-dependent expression at the different stages of colorectal cancer (CRC) in the 62 pair-matched tumor/normal tissues. In detail, ppGalNAc-T4 expression is significantly induced at stage I and II but not at stage III and IV. Overexpression of ppGalNAc-T4 in CRC cells enhances colony formation and sphere formation suggesting an important role of ppGalNAc-T4 in tumorigenesis. Conversely, knockdown of ppGalNAc-T4 in CRC cells increases the cell migration and invasion, and leads to an epithelial-mesenchymal transition-like transition. Further analysis suggests that loss of ppGalNAc-T4 contributes to the dedifferentiation of CRC and high expression of ppGalNAc-T4 correlates to a good prognosis of patients. Taken together, our results not only demonstrate a stage-dependent expression of ppGalNAc-T4 in CRC progression, but also suggest that such stage-dependent expression may contribute to the tumorigenesis at the early stage and promote cell migration and invasion at the advanced stage.
TRIM23 promotes 5-Fluorouracil resistance in colorectal cancer by upregulating GALNT4 expression.
Wei S, Xia W, Feng J, Lu J, Zhang L, Wang W Apoptosis. 2024; .
PMID: 39720975 DOI: 10.1007/s10495-024-02060-2.
Li J, Kang X, Zhu G, Zhao Z, Chen S, Guo Y Genet Test Mol Biomarkers. 2024; 28(12):461-466.
PMID: 39652342 PMC: 11659455. DOI: 10.1089/gtmb.2023.0477.
Role of Post-Translational Modifications in Colorectal Cancer Metastasis.
Peng N, Liu J, Hai S, Liu Y, Zhao H, Liu W Cancers (Basel). 2024; 16(3).
PMID: 38339403 PMC: 10854713. DOI: 10.3390/cancers16030652.
Yu S, Sun L, Peng L, Wu Z, Yu X, Li B Mol Biotechnol. 2023; 66(11):3226-3237.
PMID: 37955776 DOI: 10.1007/s12033-023-00930-9.
Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway.
Zhang B, Gao L, Yang Q, Liu Y, Yu X, Shen J Cell Death Dis. 2021; 12(11):980.
PMID: 34675184 PMC: 8531281. DOI: 10.1038/s41419-021-04222-5.